|
1
|
Xiao D and He J: Epithelial mesenchymal
transition and lung cancer. J Thorac Dis. 2:154–159.
2010.PubMed/NCBI
|
|
2
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shi Y, Wu H, Zhang M, Ding L, Meng F and
Fan X: Expression of the epithelial-mesenchymal transition-related
proteins and their clinical significance in lung adenocarcinoma.
Diagn Pathol. 8:892013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gupta GP and Massagué J: Cancer
metastasis: Building a framework. Cell. 127:679–695. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee JM, Dedhar S, Kalluri R and Thompson
EW: The epithelial-mesenchymal transition: New insights in
signaling, development, and disease. J Cell Biol. 172:973–981.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Klymkowsky MW and Savagner P:
Epithelial-mesenchymal transition: A cancer researcher's conceptual
friend and foe. Am J Pathol. 174:1588–1593. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Morel AP, Lièvre M, Thomas C, Hinkal G,
Ansieau S and Puisieux A: Generation of breast cancer stem cells
through epithelial-mesenchymal transition. PLoS One. 3:e28882008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Battula VL, Evans KW, Hollier BG, et al:
Epithelial-mesenchymal transition-derived cells exhibit
multilineage differentiation potential similar to mesenchymal stem
cells. Stem Cells. 28:1435–1445. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shien K, Toyooka S, Yamamoto H, Soh J,
Jida M, Thu KL, Hashida S, Maki Y, Ichihara E, Asano H, et al:
Acquired resistance to EGFR inhibitors is associated with a
manifestation of stem cell-like properties in cancer cells. Cancer
Res. 73:3051–3061. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Koren A, Motaln H and Cufer T: Lung cancer
stem cells: A biological and clinical perspective. Cell Oncol.
36:265–275. 2013. View Article : Google Scholar
|
|
12
|
Kim CF, Jackson EL, Woolfenden AE,
Lawrence S, Babar I, Vogel S, Crowley D, Bronson RT and Jacks T:
Identification of bronchioalveolar stem cells in normal lung and
lung cancer. Cell. 121:823–835. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Willis BC and Borok Z: TGF-beta-induced
EMT: Mechanisms and implications for fibrotic lung disease. Am J
Physiol Lung Cell Mol Physiol. 293:L525–L534. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu Y, Deng J, Rychahou PG, Qiu S, Evers BM
and Zhou BP: Stabilization of snail by NF-kappaB is required for
inflammation-induced cell migration and invasion. Cancer Cell.
15:416–428. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
De Wever O and Mareel M: Role of tissue
stroma in cancer cell invasion. J Pathol. 200:429–447. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kalluri R and Zeisberg M: Fibroblasts in
cancer. Nat Rev Cancer. 6:392–401. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Heinrich EL, Walser TC, Krysan K, Liclican
EL, Grant JL, Rodriguez NL and Dubinett SM: The inflammatory tumor
microenvironment, epithelial mesenchymal transition and lung
carcinogenesis. Cancer Microenviron. 5:5–18. 2012. View Article : Google Scholar :
|
|
18
|
Nizet V and Johnson RS: Interdependence of
hypoxic and innate immune responses. Nat Rev Immunol. 9:609–617.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fitzpatrick SF, Tambuwala MM, Bruning U,
Schaible B, Scholz CC, Byrne A, O'Connor A, Gallagher WM, Lenihan
CR, Garvey JF, et al: An intact canonical NF-κB pathway is required
for inflammatory gene expression in response to hypoxia. J Immunol.
186:1091–1096. 2011. View Article : Google Scholar
|
|
20
|
Semenza GL: Defining the role of
hypoxia-inducible factor 1 in cancer biology and therapeutics.
Oncogene. 29:625–634. 2010. View Article : Google Scholar :
|
|
21
|
Harris AL: Hypoxia - a key regulatory
factor in tumour growth. Nat Rev Cancer. 2:38–47. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Giatromanolaki A, Sivridis E and
Koukourakis MI: The pathology of tumor stromatogenesis. Cancer Biol
Ther. 6:639–645. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bonde AK, Tischler V, Kumar S, Soltermann
A and Schwendener RA: Intratumoral macrophages contribute to
epithelial-mesenchymal transition in solid tumors. BMC Cancer.
12:352012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu WH, You N, Zhang N, Yan HT, Wang T,
Huang Z, Liu HB and Tang LJ: Interpretation of interlocking key
issues of cancer stem cells in malignant solid tumors. Cell Oncol.
35:397–409. 2012. View Article : Google Scholar
|
|
26
|
Visvader JE and Lindeman GJ: Cancer stem
cells in solid tumours: Accumulating evidence and unresolved
questions. Nat Rev Cancer. 8:755–768. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sullivan JP, Minna JD and Shay JW:
Evidence for self-renewing lung cancer stem cells and their
implications in tumor initiation, progression, and targeted
therapy. Cancer Metastasis Rev. 29:61–72. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kitamura H, Okudela K, Yazawa T, Sato H
and Shimoyamada H: Cancer stem cell: Implications in cancer biology
and therapy with special reference to lung cancer. Lung Cancer.
66:275–281. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sullivan JP, Spinola M, Dodge M, Raso MG,
Behrens C, Gao B, Schuster K, Shao C, Larsen JE, Sullivan LA, et
al: Aldehyde dehydrogenase activity selects for lung adenocarcinoma
stem cells dependent on notch signaling. Cancer Res. 70:9937–9948.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan
A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Leung EL, Fiscus RR, Tung JW, Tin VP,
Cheng LC, Sihoe AD, Fink LM, Ma Y and Wong MP: Non-small cell lung
cancer cells expressing CD44 are enriched for stem cell-like
properties. PLoS One. 5:e140622010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Eramo A, Lotti F, Sette G, Pilozzi E,
Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C and De
Maria R: Identification and expansion of the tumorigenic lung
cancer stem cell population. Cell Death Differ. 15:504–514. 2008.
View Article : Google Scholar
|
|
35
|
Hilbe W, Dirnhofer S, Oberwasserlechner F,
Schmid T, Gunsilius E, Hilbe G, Wöll E and Kähler CM: CD133
positive endothelial progenitor cells contribute to the tumour
vasculature in non-small cell lung cancer. J Clin Pathol.
57:965–969. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Weber CE, Li NY, Wai PY and Kuo PC:
Epithelial-mesenchymal transition, TGF-β, and osteopontin in wound
healing and tissue remodeling after injury. J Burn Care Res.
33:311–318. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Thiery JP and Sleeman JP: Complex networks
orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell
Biol. 7:131–142. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Castro Alves C, Rosivatz E, Schott C,
Hollweck R, Becker I, Sarbia M, Carneiro F and Becker KF: Slug is
overexpressed in gastric carcinomas and may act synergistically
with SIP1 and Snail in the down-regulation of E-cadherin. J Pathol.
211:507–515. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Aamodt R, Bondi J, Andersen SN, Bakka A,
Bukholm G and Bukholm IR: The prognostic impact of protein
expression of E-cadherin-catenin complexes differs between rectal
and colon carcinoma. Gastroenterol Res Pract. 2010:616–623. 2010.
View Article : Google Scholar
|
|
40
|
Satelli A and Li S: Vimentin in cancer and
its potential as a molecular target for cancer therapy. Cell Mol
Life Sci. 68:3033–3046. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Crystal RG, Randell SH, Engelhardt JF,
Voynow J and Sunday ME: Airway epithelial cells: Current concepts
and challenges. Proc Am Thorac Soc. 5:772–777. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kidd ME, Shumaker DK and Ridge KM: The
role of vimentin intermediate filaments in the progression of lung
cancer. Am J Respir Cell Mol Biol. 50:1–6. 2014.
|
|
43
|
Schoumacher M, Goldman RD, Louvard D and
Vignjevic DM: Actin, microtubules, and vimentin intermediate
filaments cooperate for elongation of invadopodia. J Cell Biol.
189:541–556. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Helfand BT, Mendez MG, Murthy SN, Shumaker
DK, Grin B, Mahammad S, Aebi U, Wedig T, Wu YI, Hahn KM, et al:
Vimentin organization modulates the formation of lamellipodia. Mol
Biol Cell. 22:1274–1289. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Geiger TR and Peeper DS: Metastasis
mechanisms. Biochim Biophys Acta. 1796:293–308. 2009.PubMed/NCBI
|
|
46
|
Gilles C, Polette M, Zahm JM, Tournier JM,
Volders L, Foidart JM and Birembaut P: Vimentin contributes to
human mammary epithelial cell migration. J Cell Sci. 112:4615–4625.
1999.PubMed/NCBI
|
|
47
|
Kimura K, Endo Y, Yonemura Y, Heizmann CW,
Schafer BW, Watanabe Y and Sasaki T: Clinical significance of
S100A4 and E-cadherin-related adhesion molecules in non-small cell
lung cancer. Int J Oncol. 16:1125–1131. 2000.PubMed/NCBI
|
|
48
|
De Craene B and Berx G: Regulatory
networks defining EMT during cancer initiation and progression. Nat
Rev Cancer. 13:97–110. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Chang AC, Garside VC, Fournier M, Smrz J,
Vrljicak P, Umlandt P, Fuller M, Robertson G, Zhao Y, Tam A, et al:
A Notch-dependent transcriptional hierarchy promotes mesenchymal
transdifferentiation in the cardiac cushion. Dev Dyn. 243:894–905.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Allen TD, Rodriguez EM, Jones KD and
Bishop JM: Activated Notch1 induces lung adenomas in mice and
cooperates with Myc in the generation of lung adenocarcinoma.
Cancer Res. 71:6010–6018. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yuan X, Wu H, Han N, Xu H, Chu Q, Yu S,
Chen Y and Wu K: Notch signaling and EMT in non-small cell lung
cancer: Biological significance and therapeutic application. J
Hematol Oncol. 7:87–96. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Donnem T, Andersen S, Al-Shibli K, Al-Saad
S, Busund LT and Bremnes RM: Prognostic impact of Notch ligands and
receptors in nonsmall cell lung cancer: Coexpression of Notch-1 and
vascular endothelial growth factor-A predicts poor survival.
Cancer. 116:5676–5685. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Zavadil J and Böttinger EP: TGF-beta and
epithelial-to-mesenchymal transitions. Oncogene. 24:5764–5774.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Lin LC, Hsu SL, Wu CL and Hsueh CM: TGFβ
can stimulate the p38/β-catenin/PPARγ signaling pathway to promote
the EMT, invasion and migration of non-small cell lung cancer (H460
cells). Clin Exp Metastasis. 31:881–895. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Zhang HJ, Wang HY, Zhang HT, Su JM, Zhu J,
Wang HB, Zhou WY, Zhang H, Zhao MC, Zhang L, et al: Transforming
growth factor-β1 promotes lung adenocarcinoma invasion and
metastasis by epithelial-to-mesenchymal transition. Mol Cell
Biochem. 355:309–314. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Zavadil J, Cermak L, Soto-Nieves N and
Böttinger EP: Integration of TGF-beta/Smad and Jagged1/Notch
signalling in epithelial-to-mesenchymal transition. EMBO J.
23:1155–1165. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Matsuno Y, Coelho AL, Jarai G, Westwick J
and Hogaboam CM: Notch signaling mediates TGF-β1-induced
epithelial-mesenchymal transition through the induction of Snai1.
Int J Biochem Cell Biol. 44:776–789. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Vaughan AE and Chapman HA: Regenerative
activity of the lung after epithelial injury. Biochim Biophys Acta.
1832:922–930. 2013. View Article : Google Scholar
|
|
59
|
Savagner P, Kusewitt DF, Carver EA,
Magnino F, Choi C, Gridley T and Hudson LG: Developmental
transcription factor slug is required for effective
re-epithelialization by adult keratinocytes. J Cell Physiol.
202:858–866. 2005. View Article : Google Scholar
|
|
60
|
Yanagawa J, Walser TC, Zhu LX, Hong L,
Fishbein MC, Mah V, Chia D, Goodglick L, Elashoff DA, Luo J, et al:
Snail promotes CXCR2 ligand-dependent tumor progression in
non-small cell lung carcinoma. Clin Cancer Res. 15:6820–6829. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Yang Y, Ahn YH, Chen Y, Tan X, Guo L,
Gibbons DL, Ungewiss C, Peng DH, Liu X, Lin SH, et al: ZEB1
sensitizes lung adenocarcinoma to metastasis suppression by PI3K
antagonism. J Clin Invest. 124:2696–2708. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Argast GM, Krueger JS, Thomson S,
Sujka-Kwok I, Carey K, Silva S, O'Connor M, Mercado P, Mulford IJ,
Young GD, et al: Inducible expression of TGFβ, snail and Zeb1
recapitulates EMT in vitro and in vivo in a NSCLC model. Clin Exp
Metastasis. 28:593–614. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Merikallio H, Kaarteenaho R, Pääkkö P,
Lehtonen S, Hirvikoski P, Mäkitaro R, Harju T and Soini Y: Zeb1 and
twist are more commonly expressed in metastatic than primary lung
tumours and show inverse associations with claudins. J Clin Pathol.
64:136–140. 2011. View Article : Google Scholar
|
|
64
|
Kojima T, Takano K, Yamamoto T, Murata M,
Son S, Imamura M, Yamaguchi H, Osanai M, Chiba H, Himi T, et al:
Transforming growth factor-beta induces epithelial to mesenchymal
transition by down-regulation of claudin-1 expression and the fence
function in adult rat hepatocytes. Liver Int. 28:534–545. 2008.
View Article : Google Scholar
|
|
65
|
Martínez-Estrada OM, Cullerés A, Soriano
FX, Peinado H, Bolós V, Martínez FO, Reina M, Cano A, Fabre M and
Vilaró S: The transcription factors Slug and Snail act as
repressors of Claudin-1 expression in epithelial cells. Biochem J.
394:449–457. 2006. View Article : Google Scholar :
|
|
66
|
Krishnamachary B, Berg-Dixon S, Kelly B,
Agani F, Feldser D, Ferreira G, Iyer N, LaRusch J, Pak B, Taghavi
P, et al: Regulation of colon carcinoma cell invasion by
hypoxia-inducible factor 1. Cancer Res. 63:1138–1143.
2003.PubMed/NCBI
|
|
67
|
Dovey JS, Zacharek SJ, Kim CF and Lees JA:
Bmi1 is critical for lung tumorigenesis and bronchioalveolar stem
cell expansion. Proc Natl Acad Sci USA. 105:11857–11862. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Wu KJ: Direct activation of Bmi1 by
Twist1: Implications in cancer stemness, epithelial-mesenchymal
transition, and clinical significance. Chang Gung Med J.
34:229–238. 2011.PubMed/NCBI
|
|
69
|
Chiou SH, Wang ML, Chou YT, Chen CJ, Hong
CF, Hsieh WJ, Chang HT, Chen YS, Lin TW, Hsu HS, et al:
Coexpression of Oct4 and Nanog enhances malignancy in lung
adenocarcinoma by inducing cancer stem cell-like properties and
epithelial-mesenchymal transdifferentiation. Cancer Res.
70:10433–10444. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Yu M, Smolen GA, Zhang J, Wittner B,
Schott BJ, Brachtel E, Ramaswamy S, Maheswaran S and Haber DA: A
developmentally regulated inducer of EMT, LBX1, contributes to
breast cancer progression. Genes Dev. 23:1737–1742. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Sandoval J and Esteller M: Cancer
epigenomics: Beyond genomics. Curr Opin Genet Dev. 22:50–55. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Micalizzi DS, Farabaugh SM and Ford HL:
Epithelial-mesenchymal transition in cancer: Parallels between
normal development and tumor progression. J Mammary Gland Biol
Neoplasia. 15:117–134. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Giudice FS, Pinto DS Jr, Nör JE, Squarize
CH and Castilho RM: Inhibition of histone deacetylase impacts
cancer stem cells and induces epithelial-mesenchyme transition of
head and neck cancer. PLoS One. 8:e586722013. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Zhang L, Liu Z, Ma W and Wang B: The
landscape of histone acetylation involved in epithelial-mesenchymal
transition in lung cancer. J Cancer Res Ther. 9(Suppl 2): S86–S91.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Wang Y and Shang Y: Epigenetic control of
epithelial-to-mesenchymal transition and cancer metastasis. Exp
Cell Res. 319:160–169. 2013. View Article : Google Scholar
|
|
76
|
Fire A, Xu S, Montgomery MK, Kostas SA,
Driver SE and Mello CC: Potent and specific genetic interference by
double-stranded RNA in Caenorhabditis elegans. Nature. 391:806–811.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Gibbons DL, Lin W, Creighton CJ, Rizvi ZH,
Gregory PA, Goodall GJ, Thilaganathan N, Du L, Zhang Y,
Pertsemlidis A, et al: Contextual extracellular cues promote tumor
cell EMT and metastasis by regulating miR-200 family expression.
Genes Dev. 23:2140–2151. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Ma L, Young J, Prabhala H, Pan E, Mestdagh
P, Muth D, Teruya-Feldstein J, Reinhardt F, Onder TT, Valastyan S,
et al: miR 9, a MYC/MYCN activated microRNA, regulates E cadherin
and cancer metastasis. Nat Cell Biol. 12:247–256. 2010.PubMed/NCBI
|
|
80
|
Valastyan S, Reinhardt F, Benaich N,
Calogrias D, Szász AM, Wang ZC, Brock JE, Richardson AL and
Weinberg RA: A pleiotropically acting microRNA, miR 31, inhibits
breast cancer metastasis. Cell. 137:1032–1046. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Tanzer A and Stadler PF: Molecular
evolution of a microRNA cluster. J Mol Biol. 339:327–335. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Kim JW, Mori S and Nevins JR: Myc-induced
microRNAs integrate Myc-mediated cell proliferation and cell fate.
Cancer Res. 70:4820–4828. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Mestdagh P, Fredlund E, Pattyn F, Schulte
JH, Muth D, Vermeulen J, Kumps C, Schlierf S, De Preter K, Van Roy
N, et al: MYCN/c-MYC-induced microRNAs repress coding gene networks
associated with poor outcome in MYCN/c-MYC-activated tumors.
Oncogene. 29:1394–1404. 2010. View Article : Google Scholar
|
|
84
|
Ma L, Teruya-Feldstein J and Weinberg RA:
Tumour invasion and metastasis initiated by microRNA-10b in breast
cancer. Nature. 449:682–688. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Schramedei K, Mörbt N, Pfeifer G, Läuter
J, Rosolowski M, Tomm JM, von Bergen M, Horn F and Brocke-Heidrich
K: MicroRNA-21 targets tumor suppressor genes ANP32A and SMARCA4.
Oncogene. 30:2975–2985. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Mongroo PS and Rustgi AK: The role of the
miR-200 family in epithelial-mesenchymal transition. Cancer Biol
Ther. 10:219–222. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Manavalan TT, Teng Y, Litchfield LM,
Muluhngwi P, Al-Rayyan N and Klinge CM: Reduced expression of
miR-200 family members contributes to antiestrogen resistance in
LY2 human breast cancer cells. PLoS One. 8:e623342013. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Hill L, Browne G and Tulchinsky E:
ZEB/miR-200 feedback loop: At the crossroads of signal transduction
in cancer. Int J Cancer. 132:745–754. 2013. View Article : Google Scholar
|
|
89
|
Gregory PA, Bert AG, Paterson EL, Barry
SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y and Goodall GJ:
The miR-200 family and miR-205 regulate epithelial to mesenchymal
transition by targeting ZEB1 and SIP1. Nat Cell Biol. 10:593–601.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Burk U, Schubert J, Wellner U, Schmalhofer
O, Vincan E, Spaderna S and Brabletz T: A reciprocal repression
between ZEB1 and members of the miR-200 family promotes EMT and
invasion in cancer cells. EMBO Rep. 9:582–589. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Wang B, Herman-Edelstein M, Koh P, Burns
W, Jandeleit-Dahm K, Watson A, Saleem M, Goodall GJ, Twigg SM,
Cooper ME, et al: E-cadherin expression is regulated by miR-192/215
by a mechanism that is independent of the profibrotic effects of
transforming growth factor-beta. Diabetes. 59:1794–1802. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Lamouille S, Subramanyam D, Blelloch R and
Derynck R: Regulation of epithelial-mesenchymal and
mesenchymal-epithelial transitions by microRNAs. Curr Opin Cell
Biol. 25:200–207. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Vetter G, Saumet A, Moes M, Vallar L, Le
Béchec A, Laurini C, Sabbah M, Arar K, Theillet C, Lecellier CH, et
al: miR-661 expression in SNAI1-induced epithelial to mesenchymal
transition contributes to breast cancer cell invasion by targeting
Nectin-1 and StarD10 messengers. Oncogene. 29:4436–4448. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Brase JC, Wuttig D, Kuner R and Sültmann
H: Serum microRNAs as non-invasive biomarkers for cancer. Mol
Cancer. 9:3062010. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Creighton CJ, Gibbons DL and Kurie JM: The
role of epithelial-mesenchymal transition programming in invasion
and metastasis: A clinical perspective. Cancer Manag Res.
5:187–195. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Mateen S, Raina K, Agarwal C, Chan D and
Agarwal R: Silibinin synergizes with histone deacetylase and DNA
methyltransferase inhibitors in upregulating E-cadherin expression
together with inhibition of migration and invasion of human
non-small cell lung cancer cells. J Pharmacol Exp Ther.
345:206–214. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Zhang X, Liu G, Kang Y, Dong Z, Qian Q and
Ma X: N-cadherin expression is associated with acquisition of EMT
phenotype and with enhanced invasion in erlotinib-resistant lung
cancer cell lines. PLoS One. 8:e576922013. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Gao D, Vahdat LT, Wong S, Chang JC and
Mittal V: Microenvironmental regulation of epithelial-mesenchymal
transitions in cancer. Cancer Res. 72:4883–4889. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Yates C: Prostate tumor cell plasticity: A
consequence of the microenvironment. Adv Exp Med Biol. 720:81–90.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Prudkin L, Liu DD, Ozburn NC, Sun M,
Behrens C, Tang X, Brown KC, Bekele BN, Moran C and Wistuba II:
Epithelial-to-mesenchymal transition in the development and
progression of adenocarcinoma and squamous cell carcinoma of the
lung. Mod Pathol. 22:668–678. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Xue C, Plieth D, Venkov C, Xu C and
Neilson EG: The gatekeeper effect of epithelial-mesenchymal
transition regulates the frequency of breast cancer metastasis.
Cancer Res. 63:3386–3394. 2003.PubMed/NCBI
|
|
102
|
Houbaviy HB, Murray MF and Sharp PA:
Embryonic stem cell-specific MicroRNAs. Dev Cell. 5:351–358. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Lu Y, Thomson JM, Wong HY, Hammond SM and
Hogan BL: Transgenic over-expression of the microRNA miR-17–92
cluster promotes proliferation and inhibits differentiation of lung
epithelial progenitor cells. Dev Biol. 310:442–453. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Bullock MD, Sayan AE, Packham GK and
Mirnezami AH: MicroRNAs: Critical regulators of epithelial to
mesenchymal (EMT) and mesenchymal to epithelial transition (MET) in
cancer progression. Biol Cell. 104:3–12. 2012. View Article : Google Scholar
|
|
105
|
Korpal M, Lee ES, Hu G and Kang Y: The
miR-200 family inhibits epithelial-mesenchymal transition and
cancer cell migration by direct targeting of E-cadherin
transcriptional repressors ZEB1 and ZEB2. J Biol Chem.
283:14910–14914. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Krebs MG, Sloane R, Priest L, Lancashire
L, Hou JM, Greystoke A, Ward TH, Ferraldeschi R, Hughes A, Clack G,
et al: Evaluation and prognostic significance of circulating tumor
cells in patients with non-small-cell lung cancer. J Clin Oncol.
29:1556–1563. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Hofman V, Bonnetaud C, Ilie MI, Vielh P,
Vignaud JM, Fléjou JF, Lantuejoul S, Piaton E, Mourad N, Butori C,
et al: Preoperative circulating tumor cell detection using the
isolation by size of epithelial tumor cell method for patients with
lung cancer is a new prognostic biomarker. Clin Cancer Res.
17:827–835. 2011. View Article : Google Scholar
|
|
108
|
Bartis D, Mise N, Mahida RY, Eickelberg O
and Thickett DR: Epithelial-mesenchymal transition in lung
development and disease: Does it exist and is it important? Thorax.
69:760–765. 2014. View Article : Google Scholar
|
|
109
|
Buonato JM and Lazzara MJ: ERK1/2 blockade
prevents epithelial-mesenchymal transition in lung cancer cells and
promotes their sensitivity to EGFR inhibition. Cancer Res.
74:309–319. 2014. View Article : Google Scholar :
|
|
110
|
Wilson C, Nicholes K, Bustos D, Lin E,
Song Q, Stephan JP, Kirkpatrick DS and Settleman J: Overcoming
EMT-associated resistance to anti-cancer drugs via Src/FAK pathway
inhibition. Oncotarget. 5:7328–7341. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Fukuoka M, Wu YL, Thongprasert S,
Sunpaweravong P, Leong SS, Sriuranpong V, Chao TY, Nakagawa K, Chu
DT, Saijo N, et al: Biomarker analyses and final overall survival
results from a phase III, randomized, open-label, first-line study
of gefitinib versus carboplatin/paclitaxel in clinically selected
patients with advanced non-small-cell lung cancer in Asia (IPASS).
J Clin Oncol. 29:2866–2874. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Shaw AT, Kim DW, Nakagawa K, Seto T, Crinó
L, Ahn MJ, De Pas T, Besse B, Solomon BJ, Blackhall F, et al:
Crizotinib versus chemotherapy in advanced ALK-positive lung
cancer. N Engl J Med. 368:2385–2394. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Li Y, Burns JA, Cheney CA, Zhang N,
Vitelli S, Wang F, Bett A, Chastain M, Audoly LP and Zhang ZQ:
Distinct expression profiles of Notch-1 protein in human solid
tumors: Implications for development of targeted therapeutic
monoclonal antibodies. Biologics. 4:163–171. 2010.PubMed/NCBI
|
|
114
|
Sureban SM, May R, Mondalek FG, Qu D,
Ponnurangam S, Pantazis P, Anant S, Ramanujam RP and Houchen CW:
Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144
and inhibits colorectal cancer tumor growth via a Notch-1 dependent
mechanism. J Nanobiotechnology. 9:402011. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Paccione RJ, Miyazaki H, Patel V, Waseem
A, Gutkind JS, Zehner ZE and Yeudall WA: Keratin down-regulation in
vimentin-positive cancer cells is reversible by vimentin RNA
interference, which inhibits growth and motility. Mol Cancer Ther.
7:2894–2903. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Bartis D, Csongei V, Weich A, Kiss E,
Barko S, Kovacs T, Avdicevic M, D'Souza VK, Rapp J, Kvell K, et al:
Down-regulation of canonical and up-regulation of non-canonical Wnt
signalling in the carcinogenic process of squamous cell lung
carcinoma. PLoS One. 8:e573932013. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Henderson WR Jr, Chi EY, Ye X, Nguyen C,
Tien YT, Zhou B, Borok Z, Knight DA and Kahn M: Inhibition of
Wnt/β-catenin/CREB binding protein (CBP) signaling reverses
pulmonary fibrosis. Proc Natl Acad Sci USA. 107:14309–14314. 2010.
View Article : Google Scholar
|
|
118
|
Tennis MA, Van Scoyk M, Heasley LE,
Vandervest K, Weiser-Evans M, Freeman S, Keith RL, Simpson P,
Nemenoff RA and Winn RA: Prostacyclin inhibits non-small cell lung
cancer growth by a frizzled 9-dependent pathway that is blocked by
secreted frizzled-related protein 1. Neoplasia. 12:244–253. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Eramo A, Haas TL and De Maria R: Lung
cancer stem cells: Tools and targets to fight lung cancer.
Oncogene. 29:4625–4635. 2010. View Article : Google Scholar : PubMed/NCBI
|
